Possible Misdiagnosis of Myocardial Infarction Using Regulatory‐Approved and Close‐to‐Bioequivalent Upper Limits of Normal for Cardiac Troponin

4 June

Written By CCRG

Wildi, K., Rubini Gimenez, M., Boeddinghaus, J., Nestelberger, T., Lopez-Ayala, P., Koechlin, L., Gerstenberger, M., Carter, N., Bima, P., Glaeser, J., Spagnuolo, C., Miró, O., Martín-Sánchez, F., Christ, M., Keller, D., Gualandro, D., Kawecki, D., Rentsch, K., Mahfoud, F., Mueller, C. Journal of the American Heart Association DOI: 10.1161/JAHA.124.040468

Abstract: Possible misdiagnosis of acute myocardial infarction (AMI) may occur due to inappropriate upper limit of normal (ULN) for cardiac troponin and has the potential to harm patients. In this observational international multicenter study, we aimed to assess to what extent the novel hs‐cTn‐assays are affected.

2025-31-60may 2025wildi

CCRG

Possible Misdiagnosis of Myocardial Infarction Using Regulatory‐Approved and Close‐to‐Bioequivalent Upper Limits of Normal for Cardiac Troponin

The significance of possible non-occlusive mesenteric ischemia in relation to neurological outcomes in patients with refractory cardiac arrest

Right heart failure after left ventricular assist device implantation